You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Sale Disclosure
Karydas Daphne · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$85.74K
Karydas Daphne Director
MLYS
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
MLYS daily price context
Close on/before transaction
$28.91
Sep 15, 2026
First close after public filing
$28.02
Sep 18, 2026
30-day return after filing
-25.34%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,000 shares @ $28.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001816952-26-000005
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$121.8K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS Current | Sale | Sep 15, 2026 | $85.74K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Sep 15, 2026 | $36.06K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Sep 15, 2026 | $0 |